Biotech company Shire said it recently partnered with MicroHealth, a digital health company, to provide a health monitoring app tool for hemophilia A and B patients.
The collaboration with MircoHealth on the customized app tool will allow hemophilia A and B patients as well as their health care teams to monitor their conditions, Shire said in a release.
The app, which was co-created by a hemophilia patient, will allow patients to set reminders, track, store and share personal health data, including photos and bleed alerts, with their health care team members, the release said.
“At Shire, we want to do everything we can to help people manage their hemophilia and to limit the burden of the disease on their everyday lives,” Shire’s head of U.S. hematology Patty Torr said in the release.
“Shire is a long-standing partner to the hemophilia community and has served hemophilia patients with inhibitors for more than 40 years,” Torr said in the release. “Enhancing the existing MicroHealth app with new functionality and resources to address the needs of hemophilia patients with inhibitors is an important innovation for this group of patients.”
The MircoHealth app, which was originally launched in 2011, is available through a free download on Apple and Android devices.
